Scinovex
Subscribe
S

Sandro Pignata

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"ORCID https://orcid.org/0000-0002-8836-2633
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—

Top Publications

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology20171,842 citations
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology20171,842 citations
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Annals of Oncology20191,130 citations
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Annals of Oncology20191,130 citations
Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies
Annals of Surgery19991,072 citations
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer
Radiotherapy and Oncology2018387 citations
Sandro Pignata · Scinovex